Cross-control Study on the Effect of Peritoneal Rest on Peritoneal Transport Function in Peritoneal Dialysis Patients
Not Applicable
Completed
- Conditions
- Chronic Kidney Disease 5D
- Interventions
- Combination Product: peritoneal rest
- First Posted Date
- 2023-04-10
- Last Posted Date
- 2024-11-07
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 18
- Registration Number
- NCT05805813
- Locations
- 🇨🇳
Peking University People's Hospital, Beijing, Beijing, China
Salivary Drug Concentration Exploratory Study of Cetylpyridinium Chloride Buccal Tablets
Phase 4
Completed
- Conditions
- Pharyngitis AcuteGingivitis
- Interventions
- First Posted Date
- 2023-04-06
- Last Posted Date
- 2023-07-12
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 10
- Registration Number
- NCT05802628
- Locations
- 🇨🇳
Peking University People's Hospital, Beijing, Beijing, China
Evaluation of the Effectiveness of a Regional Trauma Care System for the Treatment of Patients With Severe Trauma
Not Applicable
Not yet recruiting
- Conditions
- Trauma
- Interventions
- Other: regional trauma care
- First Posted Date
- 2023-04-05
- Last Posted Date
- 2023-04-05
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 3200
- Registration Number
- NCT05799170
Radiomic fEatures of Pancreas From Contrast Enhanced CT Image Predict One-Year RecUrrence Risk of Acute PancReatitis
Not yet recruiting
- Conditions
- Pancreatitis, Chronic
- Interventions
- Diagnostic Test: Radiomics Model
- First Posted Date
- 2023-03-22
- Last Posted Date
- 2023-03-22
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 694
- Registration Number
- NCT05778929
The Effect of Preoperative SGB on POAF After VATS
Not Applicable
Recruiting
- Conditions
- Atrial Fibrillation
- Interventions
- First Posted Date
- 2023-03-03
- Last Posted Date
- 2023-04-06
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 480
- Registration Number
- NCT05753644
- Locations
- 🇨🇳
Peking University People's Hospital, Beijing, Beijing, China
SGLT2 Inhibitors and Treatment of Heart Failure in Severe Renal Insufficiency
Phase 4
Terminated
- Conditions
- Heart Failure With Reduced Ejection FractionRenal Insufficiency, Chronic
- Interventions
- Drug: SGLT-2 inhibitor
- First Posted Date
- 2023-02-21
- Last Posted Date
- 2024-04-30
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 11
- Registration Number
- NCT05737186
- Locations
- 🇨🇳
Peking University People's Hospital, Beijing, Please Select, China
Effect of Balint Group on Burnout and Self-efficacy of Nurse Leaders in China: A Randomised Controlled Trial
Not Applicable
Completed
- Conditions
- BurnoutSelf Efficacy
- Interventions
- Other: Balint group activities
- First Posted Date
- 2023-02-08
- Last Posted Date
- 2023-02-08
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT05716828
- Locations
- 🇨🇳
Shan Qu, Beijing, Beijing, China
Comparison of Post-operative Symptoms After Two Surgeries for Patients With Pelvic Organ Prolapse
Completed
- Conditions
- Pelvic Organ Prolapse
- Interventions
- Procedure: Two different surgical methods
- First Posted Date
- 2023-01-26
- Last Posted Date
- 2023-01-26
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 2
- Registration Number
- NCT05697796
- Locations
- 🇨🇳
The Peking University People's Hospital, Beijing, Beijing, China
Medroxyprogesterone Acetate Plus Atorvastatin in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia
Phase 2
Recruiting
- Conditions
- Endometrial Carcinoma Stage IAtypical Endometrial Hyperplasia
- Interventions
- Drug: Medroxyprogesterone acetate + Atorvastatin
- First Posted Date
- 2023-01-09
- Last Posted Date
- 2024-07-11
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 82
- Registration Number
- NCT05675787
- Locations
- 🇨🇳
Wang Jianliu, Peking, Beijing, China
Irinotecan and Anlotinib for Epithelioid Sarcoma
Not Applicable
Withdrawn
- Conditions
- Objective ResponseOverall Survival
- Interventions
- Drug: VIA combination treatment
- First Posted Date
- 2022-12-19
- Last Posted Date
- 2023-02-16
- Lead Sponsor
- Peking University People's Hospital
- Registration Number
- NCT05656222
- Locations
- 🇨🇳
Peking University People's Hospital, Beijing, China
© Copyright 2025. All Rights Reserved by MedPath